Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer

Mylan N.V. (NASDAQ: MYL) and Pfizer (NYSE: PFE) today announced that Sanjeev Narula, current chief financial officer (CFO) of Upjohn, a division of Pfizer, has been named incoming CFO of Viatris, the new company that will result from the planned combination of Mylan and Upjohn. Upon closing, which is expected in mid-2020, Viatris will be a new champion for global health with a portfolio of approximately 3,000 brands and molecules and a commercial presence in 165 countries.

source https://finance.yahoo.com/news/mylan-pfizer-announce-appointment-viatris-131500242.html?.tsrc=rss

Published by Noah Blaine

5+ years in the financial markets as trader and investor! I currently work full time and pursue my financial endeavors in my own time. I love writing and staying informed so this blog is my way of doing just that. To clarify I'm not a financial advisor and everything I say is my opinion and never should be taken as financial advice. Thanks!

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: